The medications work as a GIP and GLP-1 receptor agonists, activating the hormone receptors and working to slow digestion and, in turn, increase satiety and reduce food cravings
Pfizer's internal efforts to develop weight-loss drugs ran into problems last year, resulting in a trio of discontinued programmes, and it has looked externally to replace them, acquiring Metsera for $10 billion after a bidding war with Novo Nordisk last November
a , Single-nucleus RNAseq (snRNAseq) of Gclc transcripts from the indicated cells present in human mammary tissue, from previously published data 72
[DOI] [PMC free article] [PubMed] [Google Scholar] 128.Wang W., Wu Y., Zhang G., Fang H., Wang H., Zang H., Xie T., Wang W
medRxiv 2020: 2020.2010.2007.20208702